HomeRSLS • NASDAQ
add
ReShape Lifesciences Inc
Previous close
$0.18
Day range
$0.18 - $0.19
Year range
$0.14 - $2.63
Market cap
4.41M USD
Avg Volume
699.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.94M | -15.00% |
Operating expense | 3.38M | -50.77% |
Net income | -2.19M | 17.62% |
Net profit margin | -112.81 | 3.08% |
Earnings per share | -0.09 | 97.28% |
EBITDA | -2.20M | 60.52% |
Effective tax rate | -0.64% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.38M | -73.52% |
Total assets | 8.23M | -49.66% |
Total liabilities | 3.70M | -56.98% |
Total equity | 4.53M | — |
Shares outstanding | 23.46M | — |
Price to book | 0.95 | — |
Return on assets | -58.48% | — |
Return on capital | -94.46% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.19M | 17.62% |
Cash from operations | -2.07M | 59.06% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -2.08M | -140.56% |
Free cash flow | -1.31M | 59.54% |
About
Founded
2002
Headquarters
Website
Employees
29